ABBV
AbbVie Inc
264.00$
+0.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 46.6% | 39.9% | 33.3% | 29.1% | 29.1% | 29.1% | 30.0% | 28.2% | 33.6% | 27.4% | 28.1% | 25.3% | 28.5% | |
| 53.4% | 60.1% | 66.7% | 70.9% | 70.9% | 70.9% | 70.0% | 71.8% | 66.4% | 72.6% | 71.9% | 74.7% | 71.5% | |
| 12.4% | 15.4% | 15.8% | 13.5% | 14.7% | 44.9% | 15.5% | 13.8% | 14.7% | 15.5% | 16.5% | 13.8% | 15.1% | |
| 24.2% | 9.5% | 26.9% | 23.4% | 29.1% | 5.2% | 24.7% | 21.1% | 22.6% | 23.4% | 23.9% | 21.4% | 22.8% | |
| 37.1% | 37.8% | 44.0% | 43.3% | 44.4% | 80.8% | 42.0% | 40.1% | 54.3% | 37.7% | 40.3% | 36.9% | 42.2% | |
| 16.4% | 22.3% | 22.7% | 27.6% | 26.5% | -9.9% | 28.0% | 31.7% | 12.1% | 35.0% | 31.6% | 37.9% | 29.3% | |
| 4.0% | 3.9% | 5.4% | 5.0% | 5.0% | 4.6% | 5.2% | 4.8% | 4.7% | 4.3% | 4.8% | 4.4% | 4.5% | |
| 14.0% | 8.5% | 14.3% | 14.8% | 14.4% | -15.0% | 12.4% | 10.1% | 4.5% | 16.1% | 6.9% | 25.2% | 13.5% | |
| 1.2% | 2.7% | 3.1% | 5.3% | 3.6% | -14.9% | 2.8% | 4.0% | 3.3% | 5.1% | 2.3% | 3.9% | 3.7% | |
| 12.8% | 5.7% | 11.1% | 9.5% | 10.8% | -0.1% | 9.6% | 6.1% | 1.2% | 10.9% | 4.7% | 21.3% | 9.8% | |
| 34.1% | 26.9% | 36.5% | 34.6% | 33.8% | 3.5% | 33.0% | 28.2% | 22.3% | 32.3% | 24.6% | 51.0% | 33.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.